Jacquelyn Elizabeth May, BSPHARM in Anchorage, AK - Pharmacist

Jacquelyn Elizabeth May, BSPHARM is a Pharmacist based in Anchorage, Alaska. Jacquelyn Elizabeth May is licensed to practice in Alaska (license number 1101) and her current practice location is 4100 Lake Otis Pkwy, Suite 200, Anchorage, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 562-2138.

NPI number for Jacquelyn Elizabeth May is 1548250764 and her current mailing address is 4100 Lake Otis Pkwy, Suite 200, Anchorage, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1548250764.

Contact Information

	Jacquelyn Elizabeth May, BSPHARM
	4100 Lake Otis Pkwy, Suite 200, Anchorage, AK 99508-5222
	(907) 562-2138
	(907) 561-0752

Healthcare Provider's Profile

Full Name	Jacquelyn Elizabeth May
Gender	Female
Speciality	Pharmacist
Location	4100 Lake Otis Pkwy, Anchorage, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1548250764
Provider Enumeration Date: 10/27/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Jacquelyn Elizabeth May such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548250764	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1101 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jacquelyn Elizabeth May is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jacquelyn Elizabeth May, BSPHARM 4100 Lake Otis Pkwy, Suite 200, Anchorage, AK 99508-5222 Ph: (907) 562-2138	Jacquelyn Elizabeth May, BSPHARM 4100 Lake Otis Pkwy, Suite 200, Anchorage, AK 99508-5222 Ph: (907) 562-2138

News Archive

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed despite prior drug therapy. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in these patient groups.

Researchers use neuroimaging abnormalities to detect timing of abusive head trauma in infants

Researchers at Penn State College of Medicine and Penn State Milton S. Hershey Medical Center (Hershey, Pennsylvania) have categorized the appearance and evolution of abnormalities on neuroimages that represent abusive head trauma (AHT) in infants.

S2S translation systems for comunication between patients and doctors

Now, USC computer scientists, communication specialists and health professionals hope to create a cheap, robust and effective speech-to-speech (S2S) translation system for clinics, emergency rooms and even ambulances.

LSU Health researchers to investigate link between breast cancer and obesity in real time

Frank Lau, MD, Associate Professor in the Section of Plastic and Reconstructive Surgery at LSU Health New Orleans School of Medicine, has been awarded a grant by the Southeastern Society of Plastic Surgeons to improve the care and research of breast cancer and obesity.

Amira identifies novel pre-clinical candidate for autotaxin lysophosphatidic acid related program

Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin. Autotaxin is an enzyme upstream from LPA receptors and has been implicated in a number of diseases including rheumatoid arthritis, glioblastoma, lung, breast, ovarian and thyroid cancers.

Pharmacist in Anchorage, AK

Ciara M Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 W Northern Lights Blvd, Pharmacy Dept, Anchorage, AK 99517 Phone: 907-339-0560
Kelly Cutrer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12045 Brandon St, Anchorage, AK 99515 Phone: 907-631-0300 Fax: 907-631-0632
Dr. Kyle Patrick Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 673 Mdg / Sghq, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-2778
Dr. Remi Cristen Williamson, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-2117
Evan Michael Ambrose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 W Northern Lights Blvd, Anchorage, AK 99517 Phone: 907-339-0560
Timothy Paul Stone, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-332-1004
Jordan E Bell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3260 Providence Dr Ste C520, Anchorage, AK 99508 Phone: 907-212-3420 Fax: 907-212-3429

Jacquelyn Elizabeth May, BSPHARM - Pharmacist in Anchorage, AK